摘要
目的:探讨复方托吡卡胺滴眼液(美多丽)对5～9岁弱视儿童进行散瞳验光的可行性。方法:对30例(60眼)弱视儿童先后用两种散瞳剂(美多丽与阿托品眼膏)散瞳验光的结果进行对比。结果:近视组、散光组的差异无显著性;远视组美多丽与阿托品眼膏的验光结果之间有显著性差异,但两者存在相关性。结论:在特殊情况下,美多丽可以作阿托品的替代药对弱视儿童进行散瞳验光。
AIM： To study feasibility in the 5-9 years old amblyopia children who were dilated the pupil with Mydrin-P for refraction.
METHODS： After used the two kind of mydriatic （Mydrin-P and Atropine） to dilate the pupil, 30 patients （60 eyes） amblyopia children were examined with retinoscopy. The data were analyzed with SPSS.
RESULTS： The change of the myopoia and astigmatism group showed no statistical difference （P〉0.05）. And The change of the hypermetropia group showed significant difference between the two kind of mydriatic, but there was the correlation between them.
CONCLUSION： Special instance when we can not use the Atropine to dilate the pupil for amblyopia children, using the Mydrin-P are allowed.
出处
《国际眼科杂志》
CAS
2007年第3期868-869,共2页
International Eye Science
